Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.68%17.22B | 13.11%77.58B | 16.41%54.74B | 14.26%37.62B | 10.06%16.29B | 15.15%68.59B | 7.07%47.03B | 12.21%32.93B | 2.55%14.8B | 9.92%59.57B |
| Special items of operating revenue | -1.38%253.58M | -6.33%1.03B | -5.60%777.63M | -0.23%527.32M | 2.23%257.13M | -0.69%1.1B | -2.59%823.76M | -7.16%528.54M | -11.53%251.52M | -5.45%1.11B |
| Operating income | 5.57%17.47B | 12.80%78.62B | 16.03%55.52B | 14.03%38.15B | 9.93%16.55B | 14.86%69.7B | 6.89%47.85B | 11.84%33.46B | 2.28%15.05B | 9.60%60.68B |
| Operating expenses | -4.97%-14.26B | -10.77%-65.22B | -15.19%-46.32B | -12.45%-31.81B | -11.02%-13.58B | -17.58%-58.88B | -10.85%-40.21B | -16.73%-28.29B | -3.15%-12.23B | -10.65%-50.07B |
| Special items of gross profit | 1.38%-253.58M | 6.33%-1.03B | 5.60%-777.63M | 0.23%-527.32M | -2.23%-257.13M | 0.69%-1.1B | 2.59%-823.76M | 7.16%-528.54M | 11.53%-251.52M | 5.45%-1.11B |
| Gross profit | 9.23%2.96B | 27.28%12.37B | 23.65%8.42B | 25.31%5.82B | 5.50%2.71B | 2.36%9.72B | -10.89%6.81B | -9.23%4.64B | -0.22%2.57B | 6.22%9.49B |
| Selling expenses | -5.08%-162.61M | -3.08%-847.67M | -10.21%-499.51M | -9.87%-317.89M | -10.60%-154.75M | -7.22%-822.36M | 57.27%-453.22M | 57.96%-289.34M | 51.77%-139.92M | 48.30%-766.95M |
| Administrative expenses | -1.56%-680.31M | -7.34%-3.78B | -1.50%-2.05B | -2.48%-1.37B | 5.30%-669.87M | -3.50%-3.52B | 5.76%-2.02B | 0.17%-1.34B | -6.76%-707.36M | -9.20%-3.4B |
| Research and development expenses | 7.55%-652.66M | -8.38%-3.26B | -11.62%-2.23B | -16.45%-1.57B | -15.24%-705.99M | -9.44%-3.01B | -17.04%-2B | -25.88%-1.35B | -18.05%-612.62M | -20.85%-2.75B |
| Profit from asset sales | 154.38%3.25M | -63.87%5.95M | -62.53%5.33M | 2,907.99%3.5M | 291.45%1.28M | 68.44%16.45M | 131.76%14.22M | -97.61%116.26K | 1,016.77%326.28K | -80.54%9.77M |
| Revaluation surplus | 728.28%370.19M | 141.40%84.52M | -177.77%-19.55M | -365.54%-75.26M | 119.98%44.69M | -340.01%-204.16M | -57.73%25.14M | -41.73%28.34M | -774.56%-223.64M | 238.22%85.06M |
| -Changes in the fair value of other assets | 728.28%370.19M | 141.40%84.52M | -177.77%-19.55M | -365.54%-75.26M | 119.98%44.69M | -340.01%-204.16M | -57.73%25.14M | -41.73%28.34M | -774.56%-223.64M | 238.22%85.06M |
| Impairment and provision | -76.39%-253.25M | -46.58%-1.9B | -234.52%-901.81M | -172.39%-666.5M | -16.82%-143.58M | -92.68%-1.29B | 50.94%-269.58M | 47.69%-244.69M | 52.30%-122.91M | -230.38%-671.59M |
| -Other impairment is provision | -76.39%-253.25M | -46.58%-1.9B | -234.52%-901.81M | -172.39%-666.5M | -16.82%-143.58M | -92.68%-1.29B | 50.94%-269.58M | 47.69%-244.69M | 52.30%-122.91M | -230.38%-671.59M |
| Operating interest expense | -56.18%-8.42M | 3.78%-23.76M | -1.99%-19.22M | -15.81%-13.61M | -54.93%-5.39M | 22.73%-24.7M | 23.19%-18.85M | 40.72%-11.75M | 72.50%-3.48M | 68.92%-31.96M |
| Special items of operating profit | -6.47%428.48M | -21.49%2.71B | 2.61%1.37B | 2.69%917.99M | -1.18%458.14M | 48.66%3.45B | 10.86%1.34B | 7.05%893.95M | 4.50%463.61M | 28.55%2.32B |
| Adjustment items of operating profit | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 31.54%1.91B | 24.52%4.9B | 18.54%3.78B | 16.26%2.51B | 24.89%1.45B | -1.31%3.93B | -0.77%3.19B | -4.26%2.16B | -4.93%1.16B | 23.52%3.98B |
| Financing income | -64.30%4.96M | -18.46%108.21M | -35.31%62.16M | 16.86%49.96M | -41.33%13.89M | 9.90%132.71M | 70.94%96.09M | 78.00%42.75M | 120.77%23.68M | 184.39%120.75M |
| Financing cost | 30.08%-11.78M | 25.78%-61.58M | -26.69%-54.98M | -22.04%-35.32M | -13.98%-16.85M | -28.76%-82.97M | 8.45%-43.4M | -8.35%-28.94M | -1.54%-14.79M | 18.86%-64.44M |
| Special items of earning before tax | -179.95%-13.7M | 313.97%6.87M | -188.30%-7.4M | -240.47%-12.42M | -166.10%-4.89M | -110.89%-3.21M | -20.17%8.38M | -21.50%-3.65M | 5,148.23%7.4M | 618.70%29.48M |
| Earning before tax | 27.96%1.8B | 23.19%4.79B | 18.63%3.73B | 18.38%2.49B | 23.64%1.41B | -3.04%3.88B | -3.86%3.14B | -9.45%2.11B | -5.48%1.14B | 20.40%4.01B |
| After-tax profit from continuing operations | 27.48%1.57B | 20.64%3.97B | 12.12%3.1B | 13.95%2.06B | 24.62%1.23B | -9.78%3.29B | -9.04%2.77B | -13.72%1.81B | -8.88%985.39M | 20.90%3.64B |
| Earning after tax | 27.48%1.57B | 20.64%3.97B | 12.12%3.1B | 13.95%2.06B | 24.62%1.23B | -9.78%3.29B | -9.04%2.77B | -13.72%1.81B | -8.88%985.39M | 20.90%3.64B |
| Minority profit | -126.91%-19.97M | -63.15%134.68M | -4.50%135.33M | 29.01%151.05M | -6.82%74.21M | 291.60%365.42M | 9.31%141.71M | 24.48%117.08M | 27.57%79.64M | -40.12%93.32M |
| Profit attributable to shareholders | 37.41%1.59B | 31.11%3.83B | 13.02%2.97B | 12.91%1.91B | 27.39%1.15B | -17.70%2.92B | -9.86%2.62B | -15.52%1.69B | -11.12%905.75M | 24.23%3.55B |
| Basic earnings per share | 24.32%0.46 | 22.34%1.15 | 7.14%0.9 | 11.11%0.6 | 27.59%0.37 | -17.54%0.94 | -9.68%0.84 | -15.63%0.54 | -11.31%0.29 | 23.91%1.14 |
| Diluted earnings per share | 24.32%0.46 | 22.34%1.15 | 7.14%0.9 | 11.11%0.6 | 27.59%0.37 | -17.54%0.94 | -9.68%0.84 | -15.63%0.54 | -11.31%0.29 | 23.91%1.14 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.